2019 International Congress

Monday, September 23, 2019

1:45pm-3:15pm

Parkinson Kinetigraph – does it change the management of PD patients?

F. Bergquist, A. Cvejtkovic, AC. Sjöström, S. Wallerstedt (Gothenburg, Sweden)

Clinical Trials, Pharmacology and Treatment  ·  Agora 3 West, Level 3

1:45pm-3:15pm

Parkinson´s Disease, respiratory capacity and functionality: a Physical Therapy perspective

V. Israel, B. Yamaguchi, A. Silva, D. Iucksch, J. Siega (Curitiba, Brazil)

Physical and Occupational Therapy  ·  Les Muses Terrace, Level 3

1:45pm-3:15pm

Parkinson’s disease patients with both GBA and LRRK2 mutations are phenotypically similar to LRRK2 – a possible protective effect?

N. Omer, A. Thaler, L. Goldstein, A. Orr-Urtreger, M. Gana Weisz, O. Goldstein, D. Cohen Avinoam, M. Kestenbaum, M. Lioti, S. John, J. Cederbaum, A. Mirelman, N. Giladi (Tel Aviv, Israel)

Genetics  ·  Les Muses Terrace, Level 3

1:45pm-3:15pm

Parkinson’s disease and intermittent hypoxia training: beneficial or harmful?

M. Sharifi-Bonab, J. Sesink, B. Bloem, D. Devos, J. Deguil, C. Moreau (Nijmegen, Netherlands)

Clinical Trials, Pharmacology and Treatment  ·  Agora 3 West, Level 3

1:45pm-3:15pm

Parkinson’s disease in Middle East, North Africa and South Asia: Consensus from the MDS Task Force on the Middle East

H. Khalil, L. Chahine, J. Junaid Siddiqui, M. Salari, S. El-Jaafary, Z. Aldaajani, M. Abu Al-Melh, T. Mohammad, M. Abu Snineh, N. Syed, M. Bhatt, M. Habib, M. Habahbeh, S. Tabbal, B. Jeon, J. Bajwa (Irbid, Jordan)

Other  ·  Agora 2 West, Level 2

1:45pm-3:15pm

Parkinson’s disease Polygenic Risk Factor Scores in Patients with Inflammatory Bowel Disease

H. Maghzi, D. Li, E. Hogg, A. Garland-Becerra, E. Tan, A. Maghzi, D. Mcgovern, M. Tagliati (Los Angeles, CA, USA)

Genetics  ·  Les Muses Terrace, Level 3

1:45pm-3:15pm

Parkinson’s Disease Treatments and Outcomes: US v Non-US Patients

TL. Davis, M. Rafferty, K. Lyons, A. Ramirez-Zamora, H. Gao, S. Wu, F. Cubilllos, EC. Nelson (Lebanon, NH, USA)

Quality of Life  ·  Les Muses Terrace, Level 3

1:45pm-3:15pm

Parkinsonism and other motor features in familial frontotemporal dementia with mutations in the MAPT, GRN, or C9orf72 gene (LEFFTDS cohort)

A. Deutschlander, R. Savica, M. Heckman, D. Brushaber, J. Syrjanen, H. Rosen, A. Boxer, B. Boeve, Z. Wszolek (Jacksonville, FL, USA)

Genetics  ·  Les Muses Terrace, Level 3

1:45pm-3:15pm

Parotitis as Adverse Event Following BoNT Injections for Sialorrhea

K. Papesh, J. Nguyen (Las Vegas, NV, USA)

Clinical Trials, Pharmacology and Treatment  ·  Agora 3 West, Level 3

1:45pm-3:15pm

Paroxysmal asymmetric dystonic arm posturing – a less recognised but characteristic manifestation of ATP1A3-related disease

B. Balint, C. Stephen, V. Udani, C. Sankhla, N. Barad, A. Lang, K. Bhatia (Boston, MA, USA)

Rare Genetic and Metabolic Diseases  ·  Les Muses Terrace, Level 3